Concepedia

Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty

Lambert F.M van den Merkhof, Felix Zijlstra, Hans Olsson, Lars Grip, Gerrit Veen, Frits W. Bär, Marcel J. B. M. van den Brand, Maarten L. Simoons, Freek W.A. Verheugt

Journal of the American College of Cardiology · 1999 · 138 citations · 24 references

DOI

Concepts

References

24

An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction

New England Journal of Medicine · 1993 · 4.1K citations · Full text

, , +11

Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

R B Sleight, Peter Sleight, Sarah Parish et al. · PubMed · 1988 · 2.9K citations

, , +9

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

James H. Chesebro, Genell L. Knatterud, Robert Roberts et al. · Circulation · 1987 · 2.3K citations · Full text

, , +13

A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction

Cindy L. Grines, Kevin F. Browne, Jean Marco et al. · New England Journal of Medicine · 1993 · 2K citations · Full text

, , +8

The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction

The GUSTO Angiographic Investigators · New England Journal of Medicine · 1993 · 1.9K citations · Full text

, , +15